| Literature DB >> 28947467 |
Elisabeth Hahnel1, Ulrike Blume-Peytavi1, Carina Trojahn1, Gabor Dobos1, Irina Jahnke1, Vera Kanti1, Claudia Richter1, Andrea Lichterfeld-Kottner1, Natalie Garcia Bartels1, Jan Kottner1.
Abstract
OBJECTIVES: The aim of this study was to measure the prevalence of skin diseases in aged nursing home residents and to explore possible associations with demographic and medical characteristics.Entities:
Keywords: Dermatology; Elderly; Nursing Homes; Prevalence; Skin Diseases
Mesh:
Year: 2017 PMID: 28947467 PMCID: PMC5623481 DOI: 10.1136/bmjopen-2017-018283
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart of participants.
Demographic characteristics of participants (n=223)
| Female, n (%) | 151 (67.7) |
| Age (years) | |
| Mean (SD) | 83.6 (8.0) |
| Median (IQR) | 84 (78–89) |
| Barthel Index total score* | |
| Mean (SD) | 45.1 (23.8) |
| Median (IQR) | 45.0 (25.0–65.0) |
| Braden score* | |
| Mean (SD) | 17.3 (3.7) |
| Median (IQR) | 18.0 (14.0–21.0) |
| BMI (kg/m²)† | |
| Mean (SD) | 25.3 (5.1) |
| Median (IQR) | 24.6 (21.9–28.3) |
| Duration of residency (months) | |
| Mean (SD) | 42.6 (49.1) |
| Median (IQR) | 27.0 (14.0–52.0) |
| Highest educational qualification, n (%) | |
| No school qualification | 3/184 (1.6) |
| Primary school | 34/184 (18.5) |
| Secondary school | 24/184 (10.8) |
| Grammar school/A-level | 7/184 (3.8) |
| Vocational training | 90/184 (48.9) |
| University | 26/184 (14.1) |
| Number of medications per resident‡ | |
| Mean (SD) | 6.84 (3.41) |
| Median (IQR) | 6.0 (4.0–9.0) |
| Polypharmacy (≥4 medications), n (%) | 186/221 (84.2) |
| Common concomitant diseases, ICD-10 system level 1, n (%) | |
| Diseases of the circulatory system (I.00–I.99) | 184/223 (82.5) |
| Mental and behavioural disorders (F.00–F.99) | 157/223 (70.4) |
| Endocrine, nutritional and metabolic diseases (E.00–E.99) | 122/223 (54.7) |
| Diseases of the genitourinary system (N.00–N.99) | 106/223 (47.5) |
| Diseases of the nervous system (G.00–G.99) | 99/223 (44.4) |
| Diseases of the musculoskeletal system and connective tissue (M.00–M.99) | 96/223 (43.0) |
*n, 222; †n, 216; ‡n, 221.
BMI, body mass index; ICD-10, International Coding of Diseases classification.
Associations between skin diseases and demographic characteristics (bivariate)
| Skin diseases (ICD-10) | Age (years) | Gender | Barthel Index | University qualification | Duration of residency | Number of medications used |
| Xerosis cutis (L85.3) ODS >0 | – | – | – | – | – | – |
| Xerosis cutis (L85.3) ODS >1 | 1.037 (0.991 to 1.084) | 1.166 (0.555 to 2.449) | 1.001 (0.986 to 1.016) | 0.998 (0.991 to 1.005) | 1.012 (0.911 to 1.123) | |
| Xerosis cutis (L85.3) ODS >2 | 1.027 (0.993 to 1.063) | 1.039 (0.583 to 1.855) | 1.008 (0.996 to 1.020) | 0.636 (0.261 to 1.550) | 0.998 (0.992 to 1.004) | 0.934 (0.860 to 1.015) |
| Xerosis cutis (L85.3) ODS >3 | 1.022 (0.969 to 1.078) | 1.178 (0.465 to 2.982) | 1.005 (0.987 to 1.023) | 0.610 (0.133 to 2.788) | 0.988 (0.974 to 1.003) | 0.971 (0.854 to 1.103) |
| Tinea unguium (B35.1) | 1.022 (0.988 to 1.057) | 0.829 (0.462 to 1.489) | 0.998 (0.987 to 1.010) | 1.253 (0.526 to 2.985) | 0.969 (0.895 to 1.049) | |
| Seborrheic keratosis (L82) | 0.896 (0.507 to 1.580) | 1.002 (0.991 to 1.014) | 1.542 (0.648 to 3.667) | 0.997 (0.991 to 1.002) | 1.076 (0.992 to 1.166) | |
| Androgenetic alopaecia (L64.9) | 0.984 (0.952 to 1.017) | 0.999 (0.988 to 1.010) | 1.028 (0.447 to 2.362) | 0.998 (0.993 to 1.004) | 1.026 (0.949 to 1.109) | |
| Incontinence-associated dermatitis | 1.003 (0.969 to 1.037) | 0.801 (0.448 to 1.434) | 0.998 (0.986 to 1.009) | 1.873 (0.812 to 4.319) | 0.996 (0.989 to 1.002) | 0.991 (0.914 to 1.074) |
| Tinea pedis (B35.3) | 0.989 (0.955 to 1.024) | 1.569 (0.663 to 3.717) | 0.997 (0.917 to 1.083) | |||
| Other pigmentation disorders (L81.-) | 1.028 (0.989 to 1.068) | 1.305 (0.673 to 2.527) | 1.006 (0.993 to 1.019) | 0.856 (0.322 to 2.279) | 0.996 (0.989 to 1.003) | 0.998 (0.913 to 1.091) |
| Venous insufficiency (I87.2) | 1.007 (0.968 to 1.047) | 0.807 (0.417 to 1.562) | 0.837 (0.294 to 2.379) | 0.998 (0.992 to 1.005) | ||
| Actinic keratosis (L57.0) | 1.029 (0.988 to 1.071) | 1.004 (0.991 to 1.018) | 1.017 (0.380 to 2.723) | 0.993 (0.984 to 1.001) | 1.034 (0.942 to 1.134) | |
| Scar and fibrosis (L90.5) | 1.022 (0.978 to 1.067) | 1.262 (0.589 to 2.705) | 0.993 (0.979 to 1.008) | 0.882 (0.281 to 2.767) | 0.997 (0.989 to 1.005) | |
| Seborrheic dermatitis (L21.-) | 0.992 (0.467 to 2.108) | 0.993 (0.978 to 1.008) | 0.809 (0.259 to 2.526) | 0.996 (0.987 to 1.004) | 0.991 (0.893 to 1.100) | |
| Intertrigo (L30.4) | 1.290 (0.585 to 2.842) | 1.002 (0.987 to 1.017) | 0.766 (0.212 to 2.758) | 1.001 (0.994 to 1.008) | 1.099 (0.994 to 1.216) | |
| Haemangioma (D18.0) | 0.997 (0.932 to 1.024) | 1.057 (0.472 to 2.369) | 1.008 (0.992 to 1.024) | 1.067 (0.337 to 3.382) | 0.998 (0.990 to 1.006) | 1.091 (0.982 to 1.212) |
| Melanocytic naevi (D22.9) | 0.955 (0.908 to 1.004) | 0.634 (0.285 to 1.411) | 1.008 (0.992 to 1.025) | 1.255 (0.392 to 4.018) | 0.994 (0.984 to 1.005) | 1.080 (0.968 to 1.205) |
| Haemorrhage (R23.3) | 1.031 (0.981 to 1.083) | 0.538 (0.243 to 1.189) | 1.003 (0.987 to 1.020) | 1.553 (0.529 to 4.565) | 1.001 (0.993 to 1.009) | 0.985 (0.877 to 1.106) |
| Rosacea (L71.9) | 0.974 (0.927 to 1.024) | 0.704 (0.311 to 1.592) | 1.004 (0.987 to 1.021) | 1.255 (0.392 to 4.018) | 0.996 (0.986 to 1.006) | 0.987 (0.878 to 1.111) |
| Pressure ulcer (L89.-, all categories) | 1.034 (0.974 to 1.097) | 1.369 (0.473 to 3.961) | 0.986 (0.966 to 1.007) | 0.857 (0.183 to 4.012) | 1.006 (0.998 to 1.013) | 1.049 (0.918 to 1.198) |
| Neoplasm (C44.9) | 1.065 (0.999 to 1.134) | 1.737 (0.551 to 5.479) | 1.001 (0.981 to 1.022) | 1.587 (0.416 to 6.057) | 1.002 (0.993 to 1.011) | 0.957 (0.825 to 1.109) |
Bold values indicate statistical significance, underlined values indicate OR ≥2.0; OR ≤ 0.5.
ICD 10: International Coding of Diseases classification; ODS, overall dry skin score.